Active

WALLACE PHARMACEUTICALS LTD Financials

Company number
SC758342Copy
Copy
Registered office
67 Broomfield Avenue, Newton Mearns, Glasgow G77 5JR
Incorporated
09/02/2023

Company snapshot

Status
Active
Employees
10 (2026)
Latest financial data
2026
Accounts type
Total Exemption Full

Financial highlights

Latest reported figures. Okredo holds filed data for 2024–2026.

Net Assets

£790.20K2026
149.98%vs 2025

2025: £316.10K

Total Assets

£1.69M2026
36.87%vs 2025

2025: £1.23M

Cash in Bank

£227.34K2026
-29.83%vs 2025

2025: £323.99K

Total Liabilities

£887.37K2026
-1.80%vs 2025

2025: £903.66K

Employees

102026
0vs 2025

2025: 10

In 2026, WALLACE PHARMACEUTICALS LTD reported net assets of £790.20K. The same filing shows total assets of £1.69M, cash in bank of £227.34K and total liabilities of £887.37K. Reported headcount was 10 in 2026. Net Assets rose from £316.10K in 2025 to £790.20K in 2026 (149.98%). Okredo holds filed figures for 2024–2026; the table below lists every reported indicator by year. See every reported indicator by year.

Financial performance

Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.

Net Assets

£790.20K2026
149.98%from £316.10K in 2025

Year-on-year change

Net Assets as filed for 2024–2026. Every figure in this chart is also in the financial history table.

3-year financial trend (2024–2026)

How the figures WALLACE PHARMACEUTICALS LTD filed moved across the three reported years 2024, 2025 and 2026 — measured end to end rather than year on year.

Net Assets

£34.35K2024£790.20K2026
+2200%vs 2024

+380% a year compound (CAGR)

Cash in Bank

£98.80K2024£227.34K2026
+130%vs 2024

+51.7% a year compound (CAGR)

Total Assets

£971.05K2024£1.69M2026
+73.9%vs 2024

+31.9% a year compound (CAGR)

Total Liabilities

£918.87K2024£887.37K2026
-3.4%vs 2024

-1.7% a year compound (CAGR)

Employees

92024102026
+11.1%vs 2024+1

Biggest increase

Net Assets+2200%

£34.35K in 2024 to £790.20K in 2026

Biggest decrease

Total Liabilities-3.4%

£918.87K in 2024 to £887.37K in 2026

WALLACE PHARMACEUTICALS LTD's filings pull in both directions between 2024 and 2026. The steepest rise came in net assets, pointing to a strengthening balance sheet, set against a fall in total liabilities, pointing to lighter outstanding obligations. See the full year-by-year figures.

Ratios from the filed figures

Calculated from WALLACE PHARMACEUTICALS LTD's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.

Net assets to total assets
46.79%2026
Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
Liabilities to total assets
52.54%2026
Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
Cash to liabilities
25.62%2026
Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
Cash to total assets
13.46%2026
Reported cash in bank divided by reported total assets, for the latest year both were filed.

Financial history

Every indicator Okredo tracks, year by year.

Reported financial indicators for WALLACE PHARMACEUTICALS LTD by year. Amounts are as filed; a dash means the figure was not reported for that year.

Indicator202420252026
Net Assets£34.35K316.10K790.20K
Total Assets£971.05K1.23M1.69M
Cash in Bank£98.80K323.99K227.34K
Total Liabilities£918.87K903.66K887.37K
Employees91010

WALLACE PHARMACEUTICALS LTD financials: frequently asked questions

Answered from this company's own filed figures.

Yes. Okredo holds filed figures for WALLACE PHARMACEUTICALS LTD covering 2024–2026, across 5 reported indicators. The most recent reported year is 2026.

WALLACE PHARMACEUTICALS LTD reported net assets of £790.20K for 2026. That compares with £316.10K in 2025, a change of 149.98%.

WALLACE PHARMACEUTICALS LTD reported total assets of £1.69M for 2026. That compares with £1.23M in 2025, a change of 36.87%.

WALLACE PHARMACEUTICALS LTD reported cash in bank of £227.34K for 2026. That compares with £323.99K in 2025, a change of -29.83%.

WALLACE PHARMACEUTICALS LTD reported 10 employees in 2026, compared with 10 in 2025.

Between 2024 and 2026, WALLACE PHARMACEUTICALS LTD's net assets rose by 2200%, cash in bank rose by 130%, total assets rose by 73.9% and total liabilities fell by 3.4%. Net assets compounded at 380% a year across the two years to 2026, from £34.35K to £790.20K. Reported headcount went from 9 in 2024 to 10 in 2026 (+1).

Okredo holds reported figures for the years 2024, 2025, 2026. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.